Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with <scp>MASLD</scp> regardless of liver fibrosisShusuke Kumazaki, Tetsuo Takehara, Naruyasu Kakita et al.|Alimentary Pharmacology & Therapeutics|2024Cited by 20
Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLDSadatsugu Sakane, Tetsuo Takehara, Hayato Hikita et al.|Hepatology Communications|2024Cited by 16
Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus EliminationYuta Myojin, Tetsuo Takehara, Hayato Hikita et al.|Hepatology Research|2025Cited by 3
Featured CoverShusuke Kumazaki, Tetsuo Takehara, Hayato Hikita et al.|Alimentary Pharmacology & Therapeutics|2024Cited by 0
Letter: Association of serum growth differentiation factor 15 and liver‐related outcomes in patients with <scp>MASLD</scp> —Authors' replyShusuke Kumazaki, Tetsuo Takehara, Hayato Hikita et al.|Alimentary Pharmacology & Therapeutics|2024Cited by 0